These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7094511)

  • 21. Pharmacodynamics and pharmacokinetics of oral pirmenol.
    Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
    Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological and cardiovascular effects of pirmenol, a new class 1 antiarrhythmic drug.
    Dukes ID; Vaughan Williams EM; Dennis PD
    J Cardiovasc Pharmacol; 1986; 8(2):227-34. PubMed ID: 2422458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular dysfunction following cold potassium cardioplegia.
    Christakis GT; Fremes SE; Weisel RD; Ivanov J; Madonik MM; Seawright SJ; McLaughlin PR
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):243-50. PubMed ID: 3875003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure.
    Dunselman PH; Kingma JH; van Wijk LM; Dijk A; Wesseling H; Lie KI
    Drugs; 1985; 29 Suppl 4():58-64. PubMed ID: 4006780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
    Salerno DM; Fifield J; Farmer C; Hodges M
    Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modification of hemodynamics by intravenous administration of flecainide].
    Hoffmeister HM; Hepp A; Seipel L
    Z Kardiol; 1986 Mar; 75(3):176-81. PubMed ID: 3705689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
    Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractions.
    Janiczek N; Smith DE; Chang T; Sedman AJ; Stringer KA
    J Clin Pharmacol; 1997 Jun; 37(6):502-13. PubMed ID: 9208357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium.
    Hasegawa J; Hirai S; Noguchi N; Hisatome I; Kotake H; Mashiba H
    Br J Pharmacol; 1990 Apr; 99(4):815-9. PubMed ID: 2361175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute, single, intravenous doses of cibenzoline: an evaluation of safety, tolerance, and hemodynamic effects.
    Humen DP; Lesoway R; Kostuk WJ
    Clin Pharmacol Ther; 1987 May; 41(5):537-45. PubMed ID: 3568538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease.
    Meinertz T; Kersting F; Kasper W; Just H; Bechtold H; Jähnchen E
    Eur J Clin Pharmacol; 1980 Nov; 18(6):461-5. PubMed ID: 7461013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
    Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
    Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
    Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.
    Hampton EM; Anderson JL; Lutz JR; Nappi JM
    Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodilution-derived indices for assessment of left and right ventricular cardiac function in normal and impaired cardiac function.
    Trepte CJ; Eichhorn V; Haas SA; Richter HP; Goepfert MS; Kubitz JC; Goetz AE; Reuter DA
    Crit Care Med; 2011 Sep; 39(9):2106-12. PubMed ID: 21572331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of nitrous oxide administered during cardiac catheterization.
    Wynne J; Mann T; Alpert JS; Green LH; Grossman W
    JAMA; 1980 Apr; 243(14):1440-2. PubMed ID: 7359715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.